Stem cell therapy for ataxia (cerebellar and spinocerebellar) at StemCell Longevita Istanbul. MSC treatments reduce neuroinflammation, protect Purkinje cells, and release neurotrophic factors that support coordination, balance, and cerebellar circuit function.
Frequently Asked Questions About Ataxia Stem Cell Therapy
How does stem cell therapy help ataxia?
MSC therapy reduces cerebellar and spinal neuroinflammation, provides neuroprotection for Purkinje cells and other neurons critical to coordination, and releases neurotrophic factors (BDNF, NT-3) that support cerebellar circuit maintenance. Intrathecal delivery allows direct access to the CNS environment.
Which types of ataxia can benefit from stem cell therapy?
We treat spinocerebellar ataxias (SCA1, SCA2, SCA3, SCA6), Friedreich's ataxia, cerebellar ataxia from autoimmune causes, and post-viral ataxia. Each protocol is adapted to the specific ataxia subtype and disease progression.
What improvements can ataxia patients expect?
Patients commonly report stabilized or modestly improved gait, better balance, reduced fall frequency, improved fine motor coordination, and slower disease progression. The neuroprotective effects of MSC therapy can help slow the natural course of degenerative ataxias.
How is stem cell therapy delivered for ataxia?
MSC therapy for ataxia is typically delivered via IV infusion combined with intrathecal (spinal) administration to maximize CNS penetration. Most patients receive 1–2 treatment sessions, with follow-up assessments at 3 and 6 months.
International Regenerative Medicine Center
Transform Your Health with Regenerative Medicine in Istanbul
Experience the future of medicine at StemCell Longevita. Our licensed medical professionals use physician-directed regenerative medicine applications to help you pursue optimal health and longevity.
